Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer.

Papadaki MA, Stoupis G, Theodoropoulos PA, Mavroudis D, Georgoulias V, Agelaki S.

Mol Cancer Ther. 2018 Nov 6. pii: molcanther.0584.2018. doi: 10.1158/1535-7163.MCT-18-0584. [Epub ahead of print]

PMID:
30401696
2.

Stem cell technology in breast cancer: current status and potential applications.

Chiotaki R, Polioudaki H, Theodoropoulos PA.

Stem Cells Cloning. 2016 Apr 26;9:17-29. doi: 10.2147/SCCAA.S72836. eCollection 2016. Review.

3.

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.

Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, Georgoulias V, Theodoropoulos PA.

BMC Cancer. 2015 May 13;15:399. doi: 10.1186/s12885-015-1386-7.

4.

Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.

Chiotaki R, Polioudaki H, Theodoropoulos PA.

Curr Cancer Drug Targets. 2015;15(3):256-69. Review.

PMID:
25669721
5.

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.

Papadaki MA, Kallergi G, Zafeiriou Z, Manouras L, Theodoropoulos PA, Mavroudis D, Georgoulias V, Agelaki S.

BMC Cancer. 2014 Sep 3;14:651. doi: 10.1186/1471-2407-14-651.

6.

Differential nuclear shape dynamics of invasive andnon-invasive breast cancer cells are associated with actin cytoskeleton organization and stability.

Chiotaki R, Polioudaki H, Theodoropoulos PA.

Biochem Cell Biol. 2014 Aug;92(4):287-95. doi: 10.1139/bcb-2013-0120. Epub 2014 Jun 17.

7.

Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.

Sfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA.

World J Gastroenterol. 2010 Oct 21;16(39):4938-43.

8.

Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods.

Tsangaridou E, Polioudaki H, Sfakianaki R, Samiotaki M, Tzardi M, Koulentaki M, Panayotou G, Kouroumalis E, Castanas E, Theodoropoulos PA.

BMC Gastroenterol. 2010 Mar 8;10:28. doi: 10.1186/1471-230X-10-28.

9.

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D, Georgoulias V.

Cancer Lett. 2010 Feb 1;288(1):99-106. doi: 10.1016/j.canlet.2009.06.027. Epub 2009 Jul 19.

PMID:
19619935
10.

Microtubule-interacting drugs induce moderate and reversible damage to human bone marrow mesenchymal stem cells.

Polioudaki H, Kastrinaki MC, Papadaki HA, Theodoropoulos PA.

Cell Prolif. 2009 Aug;42(4):434-47. doi: 10.1111/j.1365-2184.2009.00607.x. Epub 2009 May 22.

PMID:
19486015
11.

Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells.

Akoumianaki T, Kardassis D, Polioudaki H, Georgatos SD, Theodoropoulos PA.

J Cell Sci. 2009 Apr 15;122(Pt 8):1111-8. doi: 10.1242/jcs.043034. Epub 2009 Mar 19.

12.

Synthesis and antitumor activity of peptide-paclitaxel conjugates.

Papas S, Akoumianaki T, Kalogiros C, Hadjiarapoglou L, Theodoropoulos PA, Tsikaris V.

J Pept Sci. 2007 Oct;13(10):662-71.

PMID:
17787026
13.

Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution.

Nifli AP, Theodoropoulos PA, Munier S, Castagnino C, Roussakis E, Katerinopoulos HE, Vercauteren J, Castanas E.

J Agric Food Chem. 2007 Apr 18;55(8):2873-8. Epub 2007 Mar 27.

PMID:
17385883
14.

Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.

Michalakis J, Georgatos SD, de Bree E, Polioudaki H, Romanos J, Georgoulias V, Tsiftsis DD, Theodoropoulos PA.

Ann Surg Oncol. 2007 Mar;14(3):1220-8. Epub 2007 Jan 7.

PMID:
17206477
15.

Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence.

Tsiakalou V, Tsangaridou E, Polioudaki H, Nifli AP, Koulentaki M, Akoumianaki T, Kouroumalis E, Castanas E, Theodoropoulos PA.

BMC Immunol. 2006 Sep 6;7:20.

16.

Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.

de Bree E, Theodoropoulos PA, Rosing H, Michalakis J, Romanos J, Beijnen JH, Tsiftsis DD.

Cancer Treat Rev. 2006 Oct;32(6):471-82. Epub 2006 Aug 30. Review.

PMID:
16942841
17.

Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells.

Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E.

Mol Cancer Ther. 2006 May;5(5):1342-51.

18.

Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.

de Bree E, Rosing H, Michalakis J, Romanos J, Relakis K, Theodoropoulos PA, Beijnen JH, Georgoulias V, Tsiftsis DD.

Eur J Surg Oncol. 2006 Aug;32(6):666-70. Epub 2006 Apr 17. Review.

PMID:
16618534
19.

Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.

Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, Kopnitsky MJ, Castanas E.

J Immunol Methods. 2006 Apr 20;311(1-2):189-97. Epub 2006 Mar 3.

PMID:
16554066
20.

Methylation-independent binding to histone H3 and cell cycle-dependent incorporation of HP1beta into heterochromatin.

Dialynas GK, Makatsori D, Kourmouli N, Theodoropoulos PA, McLean K, Terjung S, Singh PB, Georgatos SD.

J Biol Chem. 2006 May 19;281(20):14350-60. Epub 2006 Mar 18.

21.

Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections.

Dambaki C, Kogia C, Kampa M, Darivianaki K, Nomikos M, Anezinis P, Theodoropoulos PA, Castanas E, Stathopoulos EN.

BMC Cancer. 2005 Nov 17;5:148.

22.

Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.

Michalakis J, Georgatos SD, Romanos J, Koutala H, Georgoulias V, Tsiftsis D, Theodoropoulos PA.

Cancer Chemother Pharmacol. 2005 Dec;56(6):615-22. Epub 2005 Jul 16.

PMID:
16025289
23.

Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.

Kampa M, Nifli AP, Charalampopoulos I, Alexaki VI, Theodoropoulos PA, Stathopoulos EN, Gravanis A, Castanas E.

Exp Cell Res. 2005 Jul 1;307(1):41-51. Epub 2005 Apr 7.

PMID:
15922725
24.

Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.

Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A, Castanas E.

J Clin Endocrinol Metab. 2005 Feb;90(2):893-903. Epub 2004 Dec 7.

PMID:
15585562
25.

The inner nuclear membrane protein lamin B receptor forms distinct microdomains and links epigenetically marked chromatin to the nuclear envelope.

Makatsori D, Kourmouli N, Polioudaki H, Shultz LD, McLean K, Theodoropoulos PA, Singh PB, Georgatos SD.

J Biol Chem. 2004 Jun 11;279(24):25567-73. Epub 2004 Mar 31.

26.

Mitotic phosphorylation of histone H3 at threonine 3.

Polioudaki H, Markaki Y, Kourmouli N, Dialynas G, Theodoropoulos PA, Singh PB, Georgatos SD.

FEBS Lett. 2004 Feb 27;560(1-3):39-44.

27.

Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells.

Stathopoulos EN, Dambaki C, Kampa M, Theodoropoulos PA, Anezinis P, Delakas D, Delides GS, Castanas E.

BMC Clin Pathol. 2003 Jan 30;3:1.

28.

Histones H3/H4 form a tight complex with the inner nuclear membrane protein LBR and heterochromatin protein 1.

Polioudaki H, Kourmouli N, Drosou V, Bakou A, Theodoropoulos PA, Singh PB, Giannakouros T, Georgatos SD.

EMBO Rep. 2001 Oct;2(10):920-5. Epub 2001 Sep 24.

29.

Binding of heterochromatin protein 1 to the nuclear envelope is regulated by a soluble form of tubulin.

Kourmouli N, Dialynas G, Petraki C, Pyrpasopoulou A, Singh PB, Georgatos SD, Theodoropoulos PA.

J Biol Chem. 2001 Apr 20;276(16):13007-14. Epub 2001 Jan 24.

30.

Dynamic associations of heterochromatin protein 1 with the nuclear envelope.

Kourmouli N, Theodoropoulos PA, Dialynas G, Bakou A, Politou AS, Cowell IG, Singh PB, Georgatos SD.

EMBO J. 2000 Dec 1;19(23):6558-68.

31.

Rules to remodel by: what drives nuclear envelope disassembly and reassembly during mitosis?

Georgatos SD, Theodoropoulos PA.

Crit Rev Eukaryot Gene Expr. 1999;9(3-4):373-81. Review.

PMID:
10651254
32.

Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus.

Theodoropoulos PA, Polioudaki H, Kostaki O, Derdas SP, Georgoulias V, Dargemont C, Georgatos SD.

Cancer Res. 1999 Sep 15;59(18):4625-33.

33.

PBC68: a nuclear pore complex protein that associates reversibly with the mitotic spindle.

Theodoropoulos PA, Polioudaki H, Koulentaki M, Kouroumalis E, Georgatos SD.

J Cell Sci. 1999 Sep;112 Pt 18:3049-59.

34.

The cytoskeleton in cell volume regulation.

Moustakas A, Theodoropoulos PA, Gravanis A, Häussinger D, Stournaras C.

Contrib Nephrol. 1998;123:121-34. Review. No abstract available.

PMID:
9761965
35.
36.
37.

Self-inflicted traumatic macroglossia.

Alvi A, Theodoropoulos PA.

J Laryngol Otol. 1997 Jan;111(1):75-6.

PMID:
9292140
38.

Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B.

Stournaras C, Stiakaki E, Koukouritaki SB, Theodoropoulos PA, Kalmanti M, Fostinis Y, Gravanis A.

Biochem Pharmacol. 1996 Nov 8;52(9):1339-46.

PMID:
8937443
39.

Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover.

Koukouritaki SB, Theodoropoulos PA, Margioris AN, Gravanis A, Stournaras C.

J Cell Biochem. 1996 Aug;62(2):251-61.

PMID:
8844405
40.

Differences in the G/total actin ratio and microfilament stability between normal and malignant human keratinocytes.

Katsantonis J, Tosca A, Koukouritaki SB, Theodoropoulos PA, Gravanis A, Stournaras C.

Cell Biochem Funct. 1994 Dec;12(4):267-74.

PMID:
7834816
41.

Cytochalasin B may shorten actin filaments by a mechanism independent of barbed end capping.

Theodoropoulos PA, Gravanis A, Tsapara A, Margioris AN, Papadogiorgaki E, Galanopoulos V, Stournaras C.

Biochem Pharmacol. 1994 May 18;47(10):1875-81.

PMID:
8204105
42.

Effect of hepatocyte swelling on microtubule stability and tubulin mRNA levels.

Häussinger D, Stoll B, vom Dahl S, Theodoropoulos PA, Markogiannakis E, Gravanis A, Lang F, Stournaras C.

Biochem Cell Biol. 1994 Jan-Feb;72(1-2):12-9.

PMID:
8068241
43.

Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors.

Theodoropoulos PA, Gravanis A, Saridakis I, Stournaras C.

Cell Biochem Funct. 1992 Dec;10(4):281-8.

PMID:
1473269
44.

Hepatocyte swelling leads to rapid decrease of the G-/total actin ratio and increases actin mRNA levels.

Theodoropoulos PA, Stournaras C, Stoll B, Markogiannakis E, Lang F, Gravanis A, Häussinger D.

FEBS Lett. 1992 Oct 26;311(3):241-5.

45.

Heat shock protein HSP90 and its association with the cytoskeleton: a morphological study.

Fostinis Y, Theodoropoulos PA, Gravanis A, Stournaras C.

Biochem Cell Biol. 1992 Sep;70(9):779-86.

PMID:
1482554
46.

Evidence of an active glucose uptake in Rhizobium meliloti.

Theodoropoulos PA, Hornez JP, Courtois B, Derieux JC.

Ann Inst Pasteur Microbiol (1985). 1985 Mar-Apr;136A(2):261-9.

PMID:
4039909

Supplemental Content

Loading ...
Support Center